Skip to main content

Table 3 Stratification analysis of APOC3 3238 C/G polymorphisms in coronary artery disease cases

From: Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population

 

Cases

CC

CG

GG

n (%)

OR (95% CI)

P

n (%)

OR (95% CI)

P

n (%)

OR (95% CI)

P

Smoking status

600

414(69.0)

1(Reference)

 

114(19.0)

1(Reference)

 

72(12.0)

1(Reference)

 

 Ever

192

133(69.3)

1.00(0.78,1.29)

0.98

35(18.2)

0.96(0.64,1.45)

0.84

24(12.5)

1.04(0.64,1.70)

0.87

 Never

408

281(68.9)

0.99(0.82,1.22)

0.99

79(19.4)

1.02(0.75,1.39)

0.91

48(11.7)

0.98(0.67,1.44)

0.92

Diabetes

600

414(69.0)

1(Reference)

 

114(19.0)

1(Reference)

 

72(12.0)

1(Reference)

 

 Positive

156

107(68.6)

0.99(0.75,1.31)

0.97

30(19.2)

1.01(0.65,1.57)

0.96

19(12.2)

1.02(0.59,1.73)

0.96

 Negative

444

307(69.1)

1.00(0.83,1.21)

0.98

84(18.9)

1.00(0.73,1.35)

0.98

53(11.9)

0.99(0.68,1.45)

0.98

Obesity

600

414(69.0)

1(Reference)

 

114(19.0)

1(Reference)

 

72(12.0)

1(Reference)

 

 Positive

176

120(68.2)

0.99(0.76,1.29)

0.93

35(19.9)

1.05(0.69,1.58)

0.83

21(11.9)

0.99(0.60,1.66)

0.98

 Negative

424

294(69.3)

1.01(0.83,1.22)

0.96

79(18.6)

0.98(0.72,1.34)

0.90

51(12.0)

1.00(0.69,1.47)

0.99

Hyperlipidemia

600

414(69.0)

1(Reference)

 

114(19.0)

1(Reference)

 

72(12.0)

1(Reference)

 

 Positive

188

117(62.2)

0.90(0.69,1.17)

0.44

32(17.0)

0.90(0.59,1.37)

0.61

39(20.7)

1.73(1.13,2.64)

0.01

 Negative

412

297(72.1)

1.05(0.86,1.27)

0.66

82(19.9)

1.05(0.77,1.43)

0.77

33(8.0)

0.67(0.43,1.03)

0.07